The global market for Apheresis Station was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Apheresis stations specialize in plasma apheresis and generally have departments such as blood source management, physical examination, inspection, quality control, plasma apheresis, sterilization supply, and refrigerated transportation.

North American market for Apheresis Station is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Apheresis Station is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Apheresis Station include Grifols, CSL Behring, Takeda, Octapharma, Tiantan Biological, Shanghai RAAS Blood Products, Hualan Biological Engineering, Kedrion Biopharma, Pacific Shuanglin Bio-pharmacy, China Resources Boya Bio-pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Apheresis Station, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Apheresis Station.

The Apheresis Station market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Apheresis Station market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Apheresis Station manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Apheresis Station Market Report

Report Metric	Details
Report Name	Apheresis Station Market
Segment by Type	Immunoglobulin Clotting Factor Others
Segment by Application	Immune System Disease Treatment Blood Coagulation Disorder Treatment Other Medical Applications
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Grifols, CSL Behring, Takeda, Octapharma, Tiantan Biological, Shanghai RAAS Blood Products, Hualan Biological Engineering, Kedrion Biopharma, Pacific Shuanglin Bio-pharmacy, China Resources Boya Bio-pharmaceutical, Shenzhen Weiguang Biological Products, BioLife Plasma Services, Biotest, GC Pharma, LFB Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Apheresis Station manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Apheresis Station in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Apheresis Station Market report?

Ans: The main players in the Apheresis Station Market are Grifols, CSL Behring, Takeda, Octapharma, Tiantan Biological, Shanghai RAAS Blood Products, Hualan Biological Engineering, Kedrion Biopharma, Pacific Shuanglin Bio-pharmacy, China Resources Boya Bio-pharmaceutical, Shenzhen Weiguang Biological Products, BioLife Plasma Services, Biotest, GC Pharma, LFB Group

What are the Application segmentation covered in the Apheresis Station Market report?

Ans: The Applications covered in the Apheresis Station Market report are Immune System Disease Treatment, Blood Coagulation Disorder Treatment, Other Medical Applications

What are the Type segmentation covered in the Apheresis Station Market report?

Ans: The Types covered in the Apheresis Station Market report are Immunoglobulin, Clotting Factor, Others

1 Apheresis Station Market Overview

1.1 Product Definition

1.2 Apheresis Station by Type

1.2.1 Global Apheresis Station Market Value Comparison by Type (2024 VS 2031)

1.2.2 Immunoglobulin

1.2.3 Clotting Factor

1.2.4 Others

1.3 Apheresis Station by Application

1.3.1 Global Apheresis Station Market Value by Application (2024 VS 2031)

1.3.2 Immune System Disease Treatment

1.3.3 Blood Coagulation Disorder Treatment

1.3.4 Other Medical Applications

1.4 Global Apheresis Station Market Size Estimates and Forecasts

1.4.1 Global Apheresis Station Revenue 2020-2031

1.4.2 Global Apheresis Station Sales 2020-2031

1.4.3 Global Apheresis Station Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Apheresis Station Market Competition by Manufacturers

2.1 Global Apheresis Station Sales Market Share by Manufacturers (2020-2025)

2.2 Global Apheresis Station Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Apheresis Station Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Apheresis Station, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Apheresis Station, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Apheresis Station, Product Type & Application

2.7 Global Key Manufacturers of Apheresis Station, Date of Enter into This Industry

2.8 Global Apheresis Station Market Competitive Situation and Trends

2.8.1 Global Apheresis Station Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Apheresis Station Players Market Share by Revenue

2.8.3 Global Apheresis Station Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Apheresis Station Market Scenario by Region

3.1 Global Apheresis Station Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Apheresis Station Sales by Region: 2020-2031

3.2.1 Global Apheresis Station Sales by Region: 2020-2025

3.2.2 Global Apheresis Station Sales by Region: 2026-2031

3.3 Global Apheresis Station Revenue by Region: 2020-2031

3.3.1 Global Apheresis Station Revenue by Region: 2020-2025

3.3.2 Global Apheresis Station Revenue by Region: 2026-2031

3.4 North America Apheresis Station Market Facts & Figures by Country

3.4.1 North America Apheresis Station Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Apheresis Station Sales by Country (2020-2031)

3.4.3 North America Apheresis Station Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Apheresis Station Market Facts & Figures by Country

3.5.1 Europe Apheresis Station Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Apheresis Station Sales by Country (2020-2031)

3.5.3 Europe Apheresis Station Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Apheresis Station Market Facts & Figures by Region

3.6.1 Asia Pacific Apheresis Station Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Apheresis Station Sales by Region (2020-2031)

3.6.3 Asia Pacific Apheresis Station Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Apheresis Station Market Facts & Figures by Country

3.7.1 Latin America Apheresis Station Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Apheresis Station Sales by Country (2020-2031)

3.7.3 Latin America Apheresis Station Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Apheresis Station Market Facts & Figures by Country

3.8.1 Middle East and Africa Apheresis Station Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Apheresis Station Sales by Country (2020-2031)

3.8.3 Middle East and Africa Apheresis Station Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Apheresis Station Sales by Type (2020-2031)

4.1.1 Global Apheresis Station Sales by Type (2020-2025)

4.1.2 Global Apheresis Station Sales by Type (2026-2031)

4.1.3 Global Apheresis Station Sales Market Share by Type (2020-2031)

4.2 Global Apheresis Station Revenue by Type (2020-2031)

4.2.1 Global Apheresis Station Revenue by Type (2020-2025)

4.2.2 Global Apheresis Station Revenue by Type (2026-2031)

4.2.3 Global Apheresis Station Revenue Market Share by Type (2020-2031)

4.3 Global Apheresis Station Price by Type (2020-2031)

5 Segment by Application

5.1 Global Apheresis Station Sales by Application (2020-2031)

5.1.1 Global Apheresis Station Sales by Application (2020-2025)

5.1.2 Global Apheresis Station Sales by Application (2026-2031)

5.1.3 Global Apheresis Station Sales Market Share by Application (2020-2031)

5.2 Global Apheresis Station Revenue by Application (2020-2031)

5.2.1 Global Apheresis Station Revenue by Application (2020-2025)

5.2.2 Global Apheresis Station Revenue by Application (2026-2031)

5.2.3 Global Apheresis Station Revenue Market Share by Application (2020-2031)

5.3 Global Apheresis Station Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Grifols

6.1.1 Grifols Company Information

6.1.2 Grifols Description and Business Overview

6.1.3 Grifols Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Grifols Apheresis Station Product Portfolio

6.1.5 Grifols Recent Developments/Updates

6.2 CSL Behring

6.2.1 CSL Behring Company Information

6.2.2 CSL Behring Description and Business Overview

6.2.3 CSL Behring Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Behring Apheresis Station Product Portfolio

6.2.5 CSL Behring Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Company Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Apheresis Station Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Apheresis Station Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 Tiantan Biological

6.5.1 Tiantan Biological Company Information

6.5.2 Tiantan Biological Description and Business Overview

6.5.3 Tiantan Biological Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tiantan Biological Apheresis Station Product Portfolio

6.5.5 Tiantan Biological Recent Developments/Updates

6.6 Shanghai RAAS Blood Products

6.6.1 Shanghai RAAS Blood Products Company Information

6.6.2 Shanghai RAAS Blood Products Description and Business Overview

6.6.3 Shanghai RAAS Blood Products Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Shanghai RAAS Blood Products Apheresis Station Product Portfolio

6.6.5 Shanghai RAAS Blood Products Recent Developments/Updates

6.7 Hualan Biological Engineering

6.7.1 Hualan Biological Engineering Company Information

6.7.2 Hualan Biological Engineering Description and Business Overview

6.7.3 Hualan Biological Engineering Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Hualan Biological Engineering Apheresis Station Product Portfolio

6.7.5 Hualan Biological Engineering Recent Developments/Updates

6.8 Kedrion Biopharma

6.8.1 Kedrion Biopharma Company Information

6.8.2 Kedrion Biopharma Description and Business Overview

6.8.3 Kedrion Biopharma Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Kedrion Biopharma Apheresis Station Product Portfolio

6.8.5 Kedrion Biopharma Recent Developments/Updates

6.9 Pacific Shuanglin Bio-pharmacy

6.9.1 Pacific Shuanglin Bio-pharmacy Company Information

6.9.2 Pacific Shuanglin Bio-pharmacy Description and Business Overview

6.9.3 Pacific Shuanglin Bio-pharmacy Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Pacific Shuanglin Bio-pharmacy Apheresis Station Product Portfolio

6.9.5 Pacific Shuanglin Bio-pharmacy Recent Developments/Updates

6.10 China Resources Boya Bio-pharmaceutical

6.10.1 China Resources Boya Bio-pharmaceutical Company Information

6.10.2 China Resources Boya Bio-pharmaceutical Description and Business Overview

6.10.3 China Resources Boya Bio-pharmaceutical Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.10.4 China Resources Boya Bio-pharmaceutical Apheresis Station Product Portfolio

6.10.5 China Resources Boya Bio-pharmaceutical Recent Developments/Updates

6.11 Shenzhen Weiguang Biological Products

6.11.1 Shenzhen Weiguang Biological Products Company Information

6.11.2 Shenzhen Weiguang Biological Products Description and Business Overview

6.11.3 Shenzhen Weiguang Biological Products Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Shenzhen Weiguang Biological Products Apheresis Station Product Portfolio

6.11.5 Shenzhen Weiguang Biological Products Recent Developments/Updates

6.12 BioLife Plasma Services

6.12.1 BioLife Plasma Services Company Information

6.12.2 BioLife Plasma Services Description and Business Overview

6.12.3 BioLife Plasma Services Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.12.4 BioLife Plasma Services Apheresis Station Product Portfolio

6.12.5 BioLife Plasma Services Recent Developments/Updates

6.13 Biotest

6.13.1 Biotest Company Information

6.13.2 Biotest Description and Business Overview

6.13.3 Biotest Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Biotest Apheresis Station Product Portfolio

6.13.5 Biotest Recent Developments/Updates

6.14 GC Pharma

6.14.1 GC Pharma Company Information

6.14.2 GC Pharma Description and Business Overview

6.14.3 GC Pharma Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.14.4 GC Pharma Apheresis Station Product Portfolio

6.14.5 GC Pharma Recent Developments/Updates

6.15 LFB Group

6.15.1 LFB Group Company Information

6.15.2 LFB Group Description and Business Overview

6.15.3 LFB Group Apheresis Station Sales, Revenue and Gross Margin (2020-2025)

6.15.4 LFB Group Apheresis Station Product Portfolio

6.15.5 LFB Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Apheresis Station Industry Chain Analysis

7.2 Apheresis Station Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Apheresis Station Production Mode & Process Analysis

7.4 Apheresis Station Sales and Marketing

7.4.1 Apheresis Station Sales Channels

7.4.2 Apheresis Station Distributors

7.5 Apheresis Station Customer Analysis

8 Apheresis Station Market Dynamics

8.1 Apheresis Station Industry Trends

8.2 Apheresis Station Market Drivers

8.3 Apheresis Station Market Challenges

8.4 Apheresis Station Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Octapharma AG

Tiantan biological

Shanghai RAAS Blood Products

Hualan Biological Engineering

Kedrion Biopharma

Pacific Shuanglin Bio-pharmacy

China Resources Boya Bio-Pharmaceutical

Shenzhen Weiguang Biological Products

BioLife Plasma Services

Biotest

GC Pharma

LFB Group

List of Tables

Table 1. Global Apheresis Station Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Apheresis Station Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Apheresis Station Market Competitive Situation by Manufacturers in 2024

Table 4. Global Apheresis Station Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Apheresis Station Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Apheresis Station Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Apheresis Station Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Apheresis Station Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Apheresis Station, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Apheresis Station, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Apheresis Station, Product Type & Application

Table 12. Global Key Manufacturers of Apheresis Station, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Apheresis Station by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Apheresis Station as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Apheresis Station Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Apheresis Station Sales by Region (2020-2025) & (K Units)

Table 18. Global Apheresis Station Sales Market Share by Region (2020-2025)

Table 19. Global Apheresis Station Sales by Region (2026-2031) & (K Units)

Table 20. Global Apheresis Station Sales Market Share by Region (2026-2031)

Table 21. Global Apheresis Station Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Apheresis Station Revenue Market Share by Region (2020-2025)

Table 23. Global Apheresis Station Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Apheresis Station Revenue Market Share by Region (2026-2031)

Table 25. North America Apheresis Station Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Apheresis Station Sales by Country (2020-2025) & (K Units)

Table 27. North America Apheresis Station Sales by Country (2026-2031) & (K Units)

Table 28. North America Apheresis Station Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Apheresis Station Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Apheresis Station Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Apheresis Station Sales by Country (2020-2025) & (K Units)

Table 32. Europe Apheresis Station Sales by Country (2026-2031) & (K Units)

Table 33. Europe Apheresis Station Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Apheresis Station Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Apheresis Station Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Apheresis Station Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Apheresis Station Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Apheresis Station Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Apheresis Station Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Apheresis Station Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Apheresis Station Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Apheresis Station Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Apheresis Station Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Apheresis Station Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Apheresis Station Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Apheresis Station Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Apheresis Station Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Apheresis Station Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Apheresis Station Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Apheresis Station Sales (K Units) by Type (2020-2025)

Table 51. Global Apheresis Station Sales (K Units) by Type (2026-2031)

Table 52. Global Apheresis Station Sales Market Share by Type (2020-2025)

Table 53. Global Apheresis Station Sales Market Share by Type (2026-2031)

Table 54. Global Apheresis Station Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Apheresis Station Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Apheresis Station Revenue Market Share by Type (2020-2025)

Table 57. Global Apheresis Station Revenue Market Share by Type (2026-2031)

Table 58. Global Apheresis Station Price (US$/Unit) by Type (2020-2025)

Table 59. Global Apheresis Station Price (US$/Unit) by Type (2026-2031)

Table 60. Global Apheresis Station Sales (K Units) by Application (2020-2025)

Table 61. Global Apheresis Station Sales (K Units) by Application (2026-2031)

Table 62. Global Apheresis Station Sales Market Share by Application (2020-2025)

Table 63. Global Apheresis Station Sales Market Share by Application (2026-2031)

Table 64. Global Apheresis Station Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Apheresis Station Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Apheresis Station Revenue Market Share by Application (2020-2025)

Table 67. Global Apheresis Station Revenue Market Share by Application (2026-2031)

Table 68. Global Apheresis Station Price (US$/Unit) by Application (2020-2025)

Table 69. Global Apheresis Station Price (US$/Unit) by Application (2026-2031)

Table 70. Grifols Company Information

Table 71. Grifols Description and Business Overview

Table 72. Grifols Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Grifols Apheresis Station Product

Table 74. Grifols Recent Developments/Updates

Table 75. CSL Behring Company Information

Table 76. CSL Behring Description and Business Overview

Table 77. CSL Behring Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CSL Behring Apheresis Station Product

Table 79. CSL Behring Recent Developments/Updates

Table 80. Takeda Company Information

Table 81. Takeda Description and Business Overview

Table 82. Takeda Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Takeda Apheresis Station Product

Table 84. Takeda Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Octapharma Apheresis Station Product

Table 89. Octapharma Recent Developments/Updates

Table 90. Tiantan Biological Company Information

Table 91. Tiantan Biological Description and Business Overview

Table 92. Tiantan Biological Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Tiantan Biological Apheresis Station Product

Table 94. Tiantan Biological Recent Developments/Updates

Table 95. Shanghai RAAS Blood Products Company Information

Table 96. Shanghai RAAS Blood Products Description and Business Overview

Table 97. Shanghai RAAS Blood Products Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Shanghai RAAS Blood Products Apheresis Station Product

Table 99. Shanghai RAAS Blood Products Recent Developments/Updates

Table 100. Hualan Biological Engineering Company Information

Table 101. Hualan Biological Engineering Description and Business Overview

Table 102. Hualan Biological Engineering Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Hualan Biological Engineering Apheresis Station Product

Table 104. Hualan Biological Engineering Recent Developments/Updates

Table 105. Kedrion Biopharma Company Information

Table 106. Kedrion Biopharma Description and Business Overview

Table 107. Kedrion Biopharma Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Kedrion Biopharma Apheresis Station Product

Table 109. Kedrion Biopharma Recent Developments/Updates

Table 110. Pacific Shuanglin Bio-pharmacy Company Information

Table 111. Pacific Shuanglin Bio-pharmacy Description and Business Overview

Table 112. Pacific Shuanglin Bio-pharmacy Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Pacific Shuanglin Bio-pharmacy Apheresis Station Product

Table 114. Pacific Shuanglin Bio-pharmacy Recent Developments/Updates

Table 115. China Resources Boya Bio-pharmaceutical Company Information

Table 116. China Resources Boya Bio-pharmaceutical Description and Business Overview

Table 117. China Resources Boya Bio-pharmaceutical Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. China Resources Boya Bio-pharmaceutical Apheresis Station Product

Table 119. China Resources Boya Bio-pharmaceutical Recent Developments/Updates

Table 120. Shenzhen Weiguang Biological Products Company Information

Table 121. Shenzhen Weiguang Biological Products Description and Business Overview

Table 122. Shenzhen Weiguang Biological Products Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Shenzhen Weiguang Biological Products Apheresis Station Product

Table 124. Shenzhen Weiguang Biological Products Recent Developments/Updates

Table 125. BioLife Plasma Services Company Information

Table 126. BioLife Plasma Services Description and Business Overview

Table 127. BioLife Plasma Services Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. BioLife Plasma Services Apheresis Station Product

Table 129. BioLife Plasma Services Recent Developments/Updates

Table 130. Biotest Company Information

Table 131. Biotest Description and Business Overview

Table 132. Biotest Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Biotest Apheresis Station Product

Table 134. Biotest Recent Developments/Updates

Table 135. GC Pharma Company Information

Table 136. GC Pharma Description and Business Overview

Table 137. GC Pharma Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. GC Pharma Apheresis Station Product

Table 139. GC Pharma Recent Developments/Updates

Table 140. LFB Group Company Information

Table 141. LFB Group Description and Business Overview

Table 142. LFB Group Apheresis Station Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. LFB Group Apheresis Station Product

Table 144. LFB Group Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Apheresis Station Distributors List

Table 148. Apheresis Station Customers List

Table 149. Apheresis Station Market Trends

Table 150. Apheresis Station Market Drivers

Table 151. Apheresis Station Market Challenges

Table 152. Apheresis Station Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Apheresis Station

Figure 2. Global Apheresis Station Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Apheresis Station Market Share by Type: 2024 & 2031

Figure 4. Immunoglobulin Product Picture

Figure 5. Clotting Factor Product Picture

Figure 6. Others Product Picture

Figure 7. Global Apheresis Station Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Apheresis Station Market Share by Application: 2024 & 2031

Figure 9. Immune System Disease Treatment

Figure 10. Blood Coagulation Disorder Treatment

Figure 11. Other Medical Applications

Figure 12. Global Apheresis Station Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Apheresis Station Market Size (2020-2031) & (US$ Million)

Figure 14. Global Apheresis Station Sales (2020-2031) & (K Units)

Figure 15. Global Apheresis Station Average Price (US$/Unit) & (2020-2031)

Figure 16. Apheresis Station Report Years Considered

Figure 17. Apheresis Station Sales Share by Manufacturers in 2024

Figure 18. Global Apheresis Station Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Apheresis Station Players: Market Share by Revenue in Apheresis Station in 2024

Figure 20. Apheresis Station Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Apheresis Station Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Apheresis Station Sales Market Share by Country (2020-2031)

Figure 23. North America Apheresis Station Revenue Market Share by Country (2020-2031)

Figure 24. United States Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Apheresis Station Sales Market Share by Country (2020-2031)

Figure 27. Europe Apheresis Station Revenue Market Share by Country (2020-2031)

Figure 28. Germany Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Apheresis Station Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Apheresis Station Revenue Market Share by Region (2020-2031)

Figure 35. China Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Apheresis Station Sales Market Share by Country (2020-2031)

Figure 43. Latin America Apheresis Station Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Apheresis Station Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Apheresis Station Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Apheresis Station Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Apheresis Station by Type (2020-2031)

Figure 53. Global Revenue Market Share of Apheresis Station by Type (2020-2031)

Figure 54. Global Apheresis Station Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Apheresis Station by Application (2020-2031)

Figure 56. Global Revenue Market Share of Apheresis Station by Application (2020-2031)

Figure 57. Global Apheresis Station Price (US$/Unit) by Application (2020-2031)

Figure 58. Apheresis Station Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions